Immunogenicity and therapeutic effects of Ag85A/B chimeric DNA vaccine in mice infected with Mycobacterium tuberculosis

FEMS Immunology and Medical Microbiology

Volumn 66, Issue 3, 2012, Pages 419-426

  Liang, Yan ^a   Wu, Xueqiong ^a   Zhang, Junxian ^a   Xiao, Li ^a   Yang, Yourong ^a   Bai, Xuejuan ^a   Yu, Qi ^a   Li, Zhongming ^b   Bi, Lan ^c   Li, Ning ^a   Wu, Xiaoli ^c  

^a 309TH HOSPITAL OF PLA   (China)

^b Shanghai H and G Biotechnology Co Inc   (China)

^c Wuhan Institute of Biological Products   (China)

Author keywords

Ag85A B chimeric DNA; DNA vaccine; Immunotherapy; Mycobacterium tuberculosis

Indexed keywords

AG85A B CHIMERIC DNA VACCINE; AG85A DNA VACCINE; DNA VACCINE; GAMMA INTERFERON; MYCOBACTERIUM VACCAE VACCINE; MYCOBACTERIUM VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG EFFICACY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GENE SEQUENCE; HISTOPATHOLOGY; IMMUNOGENICITY; LIVER; LUNG; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SUPERNATANT; TH1 CELL; TH2 CELL; TUBERCULOSIS;

EID: 85027917097     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/1574-695X.12008     Document Type: Article

References (24)

1. Anderson P & Donherty TM (2005) The success and failure of BCG: implication for a novel tuberculosis vaccine. Nat Rev Microbiol 3: 656-662.
2. Bryder K, Sbai H, Nielsen HV, Corbet S, Nielsen C, Whalen RG & Fomsgaard A (1999) Improved immunogenicity of HIV-1 epitopes in HBsAg chimeric DNA vaccine plasmids by structural mutations of HBsAg. DNA Cell Biol 18: 219-225.
3. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG & Orme IM (1993) Disseminated tuberculosis in interferon gamma gene disrupted mice. J Exp Med 178: 2243-2247.
4. + T cell epitopic repertoire broader than that stimulated by M. tuberculosis H37 Rv infection. Infect Immun 66: 1527-1533.
5. Dye C & Williams BG (2010) The population dynamics and control of tuberculosis. Science 328: 856-861.
6. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA & Bloom BR (1993) An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178: 2249-2254.
7. Ha SJ, Jeon BY, Youn JI, Kim SC, Cho SN & Sung YC (2005) Protective effect of DNA vaccine during chemotherapy on reactivation and reinfection of Mycobacterium tuberculosis. Gene Ther 12: 634-638.
8. Hu J, Wu X, Wang L & Zheng Y (2006) The construction, immunogenicity and protective efficacy of tuberculosis Ag85B DNA vaccine. Sci Technol Eng 6: 1765-1771.
9. Huygen K (2006) DNA vaccines against mycobacterial diseases. Future Microbiol 1: 63-73.
10. Huygen O, Content J, Denis O et al. (1996) Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med 2: 857-859.
11. Jiang S, Zhu DY, Luo XD, Jiang Y & Chen Q (2005) Therapeutic effects of DNA vaccines in a murine model of Mycobacterium tuberculosis infection. Chin J Tuberc Respir Dis 28: 305-309.
12. Liang Y, Wu X, Zhang J et al. (2008) The treatment of mice infected with multi-drug-resistant Mycobacterium tuberculosis using DNA vaccines or in combination with rifampin. Vaccine 26: 4536-4540.
13. Liang Y, Wu X, Zhang J, Yang Y, Wang L, Bai X, Yu Q, Li N & Li Z (2011) Treatment of multi-drug-resistant tuberculosis in mice with DNA vaccines alone or in combination with chemotherapeutic drugs. Scand J Immunol 74: 42-46.
14. Lowrie DB, Tascon RE, Bonato VL, Lima VM, Faccioli LH, Stavropoulos E, Colston MJ, Hewinson RG, Moelling K & Silva CL (1999) Therapy of tuberculosis in mice by DNA vaccination. Nature 400: 269-271.
15. Lozes E, Huygen K, Content J et al. (1997) Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex. Vaccine 15: 830-833.
16. Maartens G & Wilkinson RJ (2007) Tuberculosis. Lancet 370: 2030-2043.
17. Manabe YC & Bishai WR (2000) Latent Mycobacterium tuberculosis - persistence, patience, and winning by waiting. Nat Med 6: 1327-1329.
18. Montgomery DL, Huygen K, Yawman AM, Deck RR, Dewitt CM, Content J, Liu MA & Ulmer JB (1997) Induction of humoral and cellular immune response by vaccination with M. tuberculosis antigen 85 DNA. Cell Mol Biol 43: 285-292.
19. Sheikh JA, Khuller GK & Verma I (2011) Immunotherapeutic role of Ag85B as an adjunct to antituberculous chemotherapy. J Immune Based Ther Vaccines 9: 4-11.
20. Wu XQ, Zhang JX, Li HM, Shi YC, Zhang LX, Liang JQ, Jin GF & You K (2002) The studies on therapeutic action of tuberculosis Ag85A DNA vaccines. Chin J Immunol 18: 17-22.
21. Wu XQ, Zheng Y, Xu YJ et al. (2006) The evaluation of protective efficacy of tuberculosis DNA vaccines with different dosage and by codelivery of cytokine plasmid. Cell Mol Immunol 22: 883-894.
22. Yang XF, Zhang XJ & Wang P (2009) The immunological effect of Ag85A and Ag85B DNA vaccine on rat bladder cancer. Xiandai Miniao Waike Zazhi 14: 8-11.
23. Yu DH, Hu XD & Cai H (2008) Efficient tuberculosis treatment in mice using chemotherapy and immunotherapy with combined DNA vaccines encoding Ag85B, MPT64 and MPT83. Gene Ther 15: 652-659.
24. Zhu DY, Jiang S & Luo XD (2005) Therapeutic effect of Ag85B and MPT64 DNA vaccines in a murine model of Mycobacterium tuberculosis. Vaccine 23: 4619-4624.